Holen Sie sich die Stockscreener-App
5.73
6.90%
0.37
Handel nachbörslich:
5.66
-0.07
-1.22%
Schlusskurs vom Vortag:
$5.36
Offen:
$5.39
24-Stunden-Volumen:
120.66K
Relative Volume:
0.76
Marktkapitalisierung:
$37.10M
Einnahmen:
$16.03M
Nettoeinkommen (Verlust:
$-18.83M
KGV:
-1.6371
EPS:
-3.5
Netto-Cashflow:
$-14.87M
1W Leistung:
+14.60%
1M Leistung:
-17.79%
6M Leistung:
-51.81%
1J Leistung:
-13.96%
1-Tages-Spanne:
$5.39
$5.7308
1-Wochen-Bereich:
$4.87
$5.7308
52-Wochen-Spanne:
$4.465
$19.49
Electrocore Inc Stock (ECOR) Company Profile
Firmenname
Electrocore Inc
Sektor
Branche
Telefon
973-290-0097
Adresse
200 FORGE WAY, ROCKAWAY
Vergleichen Sie ECOR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
5.73 | 37.10M | 16.03M | -18.83M | -14.87M | -3.50 |
|
ABT
Abbott Laboratories
|
133.58 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 155.73B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.23B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 106.37B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.88B | 5.54B | 4.18B | 623.10M | 7.00 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-08-14 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-11-14 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-09-26 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2019-05-30 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-15 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-05-09 | Eingeleitet | Noble Capital Markets | Outperform |
| 2018-09-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Electrocore Inc Aktie (ECOR) Neueste Nachrichten
Jane Street Group LLC Invests $278,000 in electroCore, Inc. (NASDAQ:ECOR) - Defense World
Trend Tracker for (ECOR) - news.stocktradersdaily.com
electrocore director John Gandolfo acquires $9,018 in shares By Investing.com - Investing.com South Africa
electrocore director John Gandolfo acquires $9,018 in shares - Investing.com
Trading (ECOR) With Integrated Risk Controls - news.stocktradersdaily.com
Global Vagus Nerve Stimulators Market to grow at a CAGR of 9.06% - openPR.com
When Will electroCore, Inc. (NASDAQ:ECOR) Become Profitable? - simplywall.st
Insider Buying: Thomas Errico Acquires 10,000 Shares of electroC - GuruFocus
(ECOR) Trading Report - news.stocktradersdaily.com
INVESTOR ALERTelectroCore, Inc. (ECOR)Bronstein, Gewirtz & Grossman, LLC Reminds of Class Action and Lead Plaintiff Deadline: November 25, 2019 - ACCESS Newswire
ElectroCore anticipates $30M 2025 revenue amid product line expansion - MSN
electroCore Inc (ECOR) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Acquisitions Drive Growth - GuruFocus
electroCore Inc (ECOR) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
Vagus Nerve Stimulators Market Is Booming Worldwide | LivaNova - openPR.com
Bioelectric Medicine Market Rises with Innovation in Neuromodulation Therapies | ElectroCore, Medtronic, Abbott - openPR.com
electroCore, Inc. (NASDAQ:ECOR) Q1 2025 Earnings Call Transcript - Insider Monkey
ElectroCore Reports Strong Q1 Growth and Strategic Expansion - TipRanks
Earnings call transcript: ElectroCore’s Q1 2025 revenue climbs 23%, stock dips - Investing.com
ElectroCore, Inc. (ECOR) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
electroCore Inc Reports Q1 2025 Earnings: EPS Matches Estimates at -$0.47, Revenue Slightly Misses at $6.7 Million - GuruFocus
electroCore Announces First Quarter 2025 Financial Results - GlobeNewswire
electroCore, Inc. (ECOR): A Bull Case Theory - Insider Monkey
electroCore completes acquisition of neurotechnology solution provider NeuroMetrix - Yahoo
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio By Investing.com - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore - Investing.com Nigeria
NeuroMetrix finalizes acquisition by electroCore By Investing.com - Investing.com South Africa
ElectroCore Completes Merger With NeuroMetrix - marketscreener.com
ElectroCore completes acquisition of NeuroMetrix - MassDevice
electroCore Completes Acquisition of NeuroMetrix - Medical Product Outsourcing
Electrocore Completes Acquisition Of Neurometrix - marketscreener.com
Electrocore Completes Merger with NeuroMetrix - TipRanks
electroCore Acquires NeuroMetrix, Expands Pain Management Portfolio - Investing.com Australia
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutio - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies | ECOR Stock News - GuruFocus
ECOR Completes Merger with NeuroMetrix to Bolster Health Solutions | ECOR Stock News - GuruFocus
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, ... - Bluefield Daily Telegraph
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies - GlobeNewswire
electroCore's $4.49/Share NeuroMetrix Buyout Expands Chronic Pain Treatment Portfolio - Stock Titan
Geode Capital Management LLC Reduces Position in electroCore, Inc. (NASDAQ:ECOR) - Defense World
electroCore, Inc. Announces Integration of Truvaga Plus with Apple Health App to Enhance Wellness Tracking - Nasdaq
electroCore's Truvaga™ Now Works with the Apple Health app - The Manila Times
electroCore’s Truvaga™ Now Works with the Apple Health app - GlobeNewswire
(ECOR) Trading Advice - news.stocktradersdaily.com
electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025 - GlobeNewswire
electroCore Q1 2025 Financial Results: Bioelectronic Leader Hosts Investor Webinar May 7 - Stock Titan
Finanzdaten der Electrocore Inc-Aktie (ECOR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.56%
1.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):